DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Traussnigg S, Schattenberg JM, Demir M. et al.
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Lancet Gastroenterol Hepatol 2019;
4: 781-793
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.